Tom Van de Casteele

2.6k total citations · 1 hit paper
45 papers, 1.8k citations indexed

About

Tom Van de Casteele is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Tom Van de Casteele has authored 45 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Infectious Diseases, 19 papers in Virology and 7 papers in Emergency Medicine. Recurrent topics in Tom Van de Casteele's work include HIV/AIDS drug development and treatment (26 papers), HIV Research and Treatment (19 papers) and HIV/AIDS Research and Interventions (10 papers). Tom Van de Casteele is often cited by papers focused on HIV/AIDS drug development and treatment (26 papers), HIV Research and Treatment (19 papers) and HIV/AIDS Research and Interventions (10 papers). Tom Van de Casteele collaborates with scholars based in Belgium, United States and United Kingdom. Tom Van de Casteele's co-authors include Erik Matthysen, Peter Galbusera, Magda Opsomer, Erkki Lathouwers, Frank Adriaensen, Thomas N. Kakuda, Frank Tomaka, Martien J. Kas, Bernhard Voelkl and Holger Schielzeth and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nature reviews. Neuroscience and Scientific Reports.

In The Last Decade

Tom Van de Casteele

45 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Reproducibility of animal research in light of biological variation

2020 224 citations Bernhard Voelkl, Naomi Altman et al. Nature reviews. Neuroscience profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tom Van de Casteele Belgium	23	589	408	288	243	219	45	1.8k
Nancy Schultz‐Darken United States	29	317 0.5×	389 1.0×	172 0.6×	457 1.9×	255 1.2×	59	2.7k
Ross P. Tarara United States	28	698 1.2×	708 1.7×	56 0.2×	48 0.2×	197 0.9×	82	2.5k
Erin E. Morgan United States	32	893 1.5×	1.0k 2.5×	37 0.1×	41 0.2×	74 0.3×	126	2.7k
Uberto Pozzoli Italy	33	334 0.6×	128 0.3×	120 0.4×	41 0.2×	634 2.9×	109	3.5k
Kenneth R. Henry United States	30	166 0.3×	163 0.4×	265 0.9×	120 0.5×	119 0.5×	139	3.0k
Yasuhiro Yoshikawa Japan	35	799 1.4×	347 0.9×	65 0.2×	216 0.9×	581 2.7×	244	4.6k
David A. Padgett United States	38	188 0.3×	45 0.1×	131 0.5×	146 0.6×	328 1.5×	66	4.9k
Álvaro Arjona‐Sánchez Spain	30	284 0.5×	144 0.4×	29 0.1×	47 0.2×	162 0.7×	122	3.4k
Shelli Farhadian United States	15	563 1.0×	144 0.4×	41 0.1×	39 0.2×	1.0k 4.7×	40	2.7k
Anna J. Jasinska United States	25	185 0.3×	141 0.3×	56 0.2×	87 0.4×	551 2.5×	61	2.0k

Countries citing papers authored by Tom Van de Casteele

Since Specialization

Citations

This map shows the geographic impact of Tom Van de Casteele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Van de Casteele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Van de Casteele more than expected).

Fields of papers citing papers by Tom Van de Casteele

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Van de Casteele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Van de Casteele. The network helps show where Tom Van de Casteele may publish in the future.

Co-authorship network of co-authors of Tom Van de Casteele

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Van de Casteele. A scholar is included among the top collaborators of Tom Van de Casteele based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Van de Casteele. Tom Van de Casteele is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Burger, Hans Ulrich, Tom Van de Casteele, Khadija Rantell, et al.. (2023). Opportunities and challenges with decentralized trials in Neuroscience. Biometrical Journal. 65(8). e2200370–e2200370. 2 indexed citations

Deligianni, Christina, Casper Emil Christensen, William Kristian Karlsson, et al.. (2023). The effect of Lu AG09222 on PACAP38- and VIP-induced vasodilation, heart rate increase, and headache in healthy subjects: an interventional, randomized, double-blind, parallel-group, placebo-controlled study. The Journal of Headache and Pain. 24(1). 60–60. 24 indexed citations

Faes, Christel, et al.. (2021). Comparison of commonly used methods in random effects meta-analysis: application to preclinical data in drug discovery research. SHILAP Revista de lepidopterología. 5(1). e100074–e100074. 50 indexed citations

Würbel, Hanno, Bernhard Voelkl, Naomi Altman, et al.. (2020). Reply to ‘It is time for an empirically informed paradigm shift in animal research’. Nature reviews. Neuroscience. 21(11). 661–662. 3 indexed citations

Voelkl, Bernhard, Naomi Altman, Anders Forsman, et al.. (2020). Reproducibility of animal research in light of biological variation. Nature reviews. Neuroscience. 21(7). 384–393. 224 indexed citations breakdown →

Voelkl, Bernhard, Naomi Altman, Anders Forsman, et al.. (2020). Author Correction: Reproducibility of animal research in light of biological variation. Nature reviews. Neuroscience. 21(7). 394–394. 3 indexed citations

Praet, Jelle, Nikolay V. Manyakov, Leacky Muchene, et al.. (2018). Diffusion kurtosis imaging allows the early detection and longitudinal follow-up of amyloid-β-induced pathology. Alzheimer s Research & Therapy. 10(1). 1–1. 76 indexed citations

Ahnaou, A., Diederik Moechars, R. Biermans, et al.. (2017). Emergence of early alterations in network oscillations and functional connectivity in a tau seeding mouse model of Alzheimer’s disease pathology. Scientific Reports. 7(1). 14189–14189. 70 indexed citations

Ahnaou, A., et al.. (2017). Cortical high gamma network oscillations and connectivity: a translational index for antipsychotics to normalize aberrant neurophysiological activity. Translational Psychiatry. 7(12). 1285–1285. 51 indexed citations

10.

Violari, Avy, Rosa Bologna, Nagalingeswaran Kumarasamy, et al.. (2015). Safety and Efficacy of Darunavir/Ritonavir in Treatment-experienced Pediatric Patients. The Pediatric Infectious Disease Journal. 34(5). e132–e137. 13 indexed citations

11.

Flynn, Patricia M., Stéphane Blanche, Carlo Giaquinto, et al.. (2014). Efficacy and Safety of Darunavir/Ritonavir at 48 Weeks in Treatment-naïve, HIV-1–infected Adolescents. The Pediatric Infectious Disease Journal. 33(9). 940–945. 20 indexed citations

12.

Kakuda, Thomas N., Lorant Leopold, Maarten Timmers, et al.. (2014). Bioavailability and bioequivalence of a darunavir 800-mg tablet formulation compared with the 400-mg tablet formulation. International Journal of Clinical Pharmacology and Therapeutics. 52(9). 805–816. 6 indexed citations

13.

Kakuda, Thomas N., Magda Opsomer, Maarten Timmers, et al.. (2014). Pharmacokinetics of darunavir in fixed‐dose combination with cobicistat compared with coadministration of darunavir and ritonavir as single agents in healthy volunteers. The Journal of Clinical Pharmacology. 54(8). 949–957. 40 indexed citations

14.

Arathoon, Eduardo, Stefan Schneider, P.L. Lim, et al.. (2013). Effects of once-daily darunavir/ritonavir versus lopinavir/ritonavir on metabolic parameters in treatment-naive HIV-1-infected patients at week 96: ARTEMIS. International Journal of STD & AIDS. 24(1). 12–17. 14 indexed citations

15.

Fourie, Jan, Jason Flamm, Peré Domingo, et al.. (2011). Effect of Baseline Characteristics on the Efficacy and Safety of Once-Daily Darunavir/ Ritonavir in HIV-1–Infected, Treatment-Naïve ARTEMIS Patients at Week 96. HIV Clinical Trials. 12(6). 313–322. 9 indexed citations

16.

Cahn, Pedro, Jan Fourie, Beatriz Grinsztejn, et al.. (2011). Week 48 analysis of once-daily vs. twice-daily darunavir/ritonavir in treatment-experienced HIV-1-infected patients. AIDS. 25(7). 929–939. 75 indexed citations

17.

Olszewska, Wieslawa, Gabriela Ispas, Corinna Schnoeller, et al.. (2010). Antiviral and lung protective activity of a novel respiratory syncytial virus fusion inhibitor in a mouse model. European Respiratory Journal. 38(2). 401–408. 42 indexed citations

18.

Matthysen, Erik, Thijs van Overveld, Tom Van de Casteele, & Frank Adriaensen. (2009). Family movements before independence influence natal dispersal in a territorial songbird. Oecologia. 162(3). 591–597. 27 indexed citations

19.

Casteele, Tom Van de. (2003). Seasonal and lifetime reproductive consequences of inbreeding in the great tit Parus major. Behavioral Ecology. 14(2). 165–174. 26 indexed citations

20.

Casteele, Tom Van de, Peter Galbusera, & Erik Matthysen. (2001). A comparison of microsatellite‐based pairwise relatedness estimators. Molecular Ecology. 10(6). 1539–1549. 207 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact